Risk of tuberculosis reactivation with tofacitinib (CP-690550).
暂无分享,去创建一个
W. Bishai | K. Winglee | N. Ammerman | Nicole C. Ammerman | M. Maiga | Haidan Guo | S. Lun
暂无分享,去创建一个
W. Bishai | K. Winglee | N. Ammerman | Nicole C. Ammerman | M. Maiga | Haidan Guo | S. Lun